OraSure Technologies, Inc. (OSUR)

Compare

3.1100

-0.1100

(-3.42%)

At close: April 4 at 4:00:02 PM EDT

3.1100

0.00

(0.00%)

After hours: April 4 at 4:05:09 PM EDT

OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025

We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where OraSure Technologies, Inc. (NASDAQ:OSUR) stands against other micro-cap stocks insiders were buying in Q1 2025. The White House announced Tuesday that Trump’s tariffs would take effect immediately after […]

Insider Monkey 3 days ago

OSUR
-3.42%
OraSure Announces $40 Million Stock Repurchase Program

BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Directors has authorized the repurchase of up to $40 million of its common stock over the next twenty-four months, which will be funded from cash on hand. The Company may repurchase the shares through various methods in compliance with applicable state and federal securi

GlobeNewswire 12 days ago

OSUR
-3.42%
OraSure Technologies Leads The Charge With 2 Other Promising Penny Stocks

As the U.S. stock market faces a challenging period with major indices like the Dow and S&P 500 on track for their worst week in two years, investors are increasingly seeking opportunities that may offer resilience amid economic uncertainty. Penny stocks, despite their somewhat outdated moniker, continue to represent an intriguing investment area for those interested in smaller or emerging companies with potential upside. By focusing on firms with strong financials and growth potential,...

Simply Wall St. 29 days ago

TBLA

TBLAW

OSUR
-3.42%
Undervalued Small Caps With Insider Buying In The Region

Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 14% over the past year with earnings forecasted to grow annually by the same percentage. In this dynamic environment, identifying small-cap stocks that are perceived as undervalued and have insider buying activity can indicate potential opportunities for investors seeking growth.

Simply Wall St. 30 days ago

AGL

OSUR
-3.42%
ACIC
President of OraSure Technologies Carrie Eglinton Manner Buys 6.7% More Shares

Investors who take an interest in OraSure Technologies, Inc. ( NASDAQ:OSUR ) should definitely note that the President...

Simply Wall St. last month

OSUR
-3.42%
OraSure Technologies Full Year 2024 Earnings: EPS Misses Expectations

OraSure Technologies ( NASDAQ:OSUR ) Full Year 2024 Results Key Financial Results Revenue: US$185.8m (down 54% from FY...

Simply Wall St. last month

OSUR
-3.42%
Q4 2024 OraSure Technologies Inc Earnings Call

Q4 2024 OraSure Technologies Inc Earnings Call

Thomson Reuters StreetEvents last month

OSUR
-3.42%
OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights: Strong Core Revenue Growth ...

OraSure Technologies Inc (OSUR) reports a 10% increase in core revenue and strategic advancements despite challenges in international markets and funding uncertainties.

GuruFocus.com last month

OSUR
-3.42%
OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of -200% and 2.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

OSUR
-3.42%
OraSure: Q4 Earnings Snapshot

OSUR) on Tuesday reported a loss of $10.8 million in its fourth quarter. The Bethlehem, Pennsylvania-based company said it had a loss of 14 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 6 cents per share.

Associated Press Finance last month

OSUR
-3.42%
OraSure Reports Fourth Quarter 2024 Financial Results

BETHLEHEM, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended December 31, 2024. “Our Q4 revenue was consistent with our expectations, including 10% growth in our core revenue. We continue to see signs of gradual recovery in our key end markets, and we are diversifying our business by expanding our product portfolio a

GlobeNewswire last month

OSUR
-3.42%
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and acc

GlobeNewswire last month

OSUR
-3.42%
Research Solutions And 2 Other Penny Stocks On The US Market To Watch

Stocks in the United States have shown mixed performance recently, with the Dow Jones and S&P 500 nearing record highs amid a flurry of earnings reports. In this context, penny stocks remain an intriguing area for investors due to their potential for growth at lower price points. While often associated with smaller or newer companies, these stocks can offer significant opportunities when backed by strong financials and fundamentals.

Simply Wall St. last month

RSSS

FOSL

OSUR
-3.42%
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?

OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 2 months ago

OSUR
-3.42%
Should Value Investors Buy OraSure Technologies (OSUR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

OSUR
-3.42%
US Penny Stocks To Consider In January 2025

As we step into January 2025, the U.S. stock market is experiencing a downturn with major indices like the S&P 500 and Nasdaq Composite sliding due to rising Treasury yields and mixed economic data. In this climate, investors often look for opportunities in less conventional areas such as penny stocks, which can offer growth potential at lower price points despite their historical reputation as high-risk investments. While the term "penny stock" may seem outdated, these smaller or newer...

Simply Wall St. 2 months ago

DRTS

DRTSW

OSUR
-3.42%
OraSure to Present at the J.P Morgan Healthcare Conference

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate in the 43rd Annual J.P. Morgan Healthcare Conference. OraSure’s presentation is scheduled for Thursday, January 16, 2025 at 9:00 a.m. PT. A live webcast and replay of the presentation will be available in the “Events and Presentations” section of OraSur

GlobeNewswire 2 months ago

OSUR
-3.42%
Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 2 months ago

OSUR
-3.42%
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence of the release (read "OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents.") is incomplete. The corrected release follows: OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announ

GlobeNewswire 2 months ago

OSUR
-3.42%
OraQuick® HIV Self-Test Now Approved for Use in Adolescents

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Self-Test. Previously the test was approved for use in those 17 and older. According to the most recent data available from the Centers for Disease Control & Prevention, it is estimated that 19 percent of new HIV diagnoses in the United States were among

GlobeNewswire 2 months ago

OSUR
-3.42%

Performance Overview

Return	OSUR	S&P 500 (^GSPC)
YTD	-13.85%	-13.73%
1-Year	-48.25%	-1.42%
3-Year	-56.32%	+10.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

OraSure Technologies, Inc. (OSUR)

OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025

OraSure Announces $40 Million Stock Repurchase Program

OraSure Technologies Leads The Charge With 2 Other Promising Penny Stocks

Undervalued Small Caps With Insider Buying In The Region

President of OraSure Technologies Carrie Eglinton Manner Buys 6.7% More Shares

OraSure Technologies Full Year 2024 Earnings: EPS Misses Expectations

Q4 2024 OraSure Technologies Inc Earnings Call

OraSure Technologies Inc (OSUR) Q4 2024 Earnings Call Highlights: Strong Core Revenue Growth ...

OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates

OraSure: Q4 Earnings Snapshot

OraSure Reports Fourth Quarter 2024 Financial Results

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

Research Solutions And 2 Other Penny Stocks On The US Market To Watch

OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Should Value Investors Buy OraSure Technologies (OSUR) Stock?

US Penny Stocks To Consider In January 2025

OraSure to Present at the J.P Morgan Healthcare Conference

Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

OraQuick® HIV Self-Test Now Approved for Use in Adolescents

Performance Overview